Siddamma Amoghimath1, R N Suresha2, M K Jayanthi3, S L Shruthi1, Ps Vaibhavi1, A M Satish4, V H Pushpa4, H L Kalabharathi4. 1. PG Student, Department of Pharmacology, JSS Medical College , Mysore, Karnataka, India . 2. Professor, Department of Pharmacology, JSS Medical College , Mysore, Karnataka, India . 3. Professor and Head, Department of Pharmacology, JSS Medical College , Mysore, Karnataka, India . 4. Associate Professor, Department of Pharmacology, JSS Medical College , Mysore, Karnataka, India .
Abstract
OBJECTIVE: To evaluate the effect of Edrophonium on blood glucose levels in euglycemic albino rats through OGTT. MATERIALS AND METHODS: Twelve Swiss albino rats weighing around 150-200 gms of either sex were randomly selected from the central animal facility, JSSMC, Mysore and divided into two groups. The control group received distilled water (25ml/kg body wt.) per orally, test groups received Edrophonium (6.3mg/kg/day) intravenously for five days. On the fifth day, following overnight fasting, half an hour after drug administration in all the groups of rats Oral Glucose Tolerance Test was performed, by administering oral glucose in dose of 0.6gm/kg body weight. The capillary blood glucose levels were measured at 0, 60 and 150 min, by rat tail snipping method using (ACCUCHEK) glucometer. RESULTS: The Capillary Blood Glucose levels of Edrophonium group was less when compared to control group at all-time intervals. CONCLUSION: Edrophonium showed the hypoglycemic activity when given for five days intravenously in euglycemic albino rats through Oral Glucose Tolerance Test.
OBJECTIVE: To evaluate the effect of Edrophonium on blood glucose levels in euglycemic albino rats through OGTT. MATERIALS AND METHODS: Twelve Swiss albino rats weighing around 150-200 gms of either sex were randomly selected from the central animal facility, JSSMC, Mysore and divided into two groups. The control group received distilled water (25ml/kg body wt.) per orally, test groups received Edrophonium (6.3mg/kg/day) intravenously for five days. On the fifth day, following overnight fasting, half an hour after drug administration in all the groups of ratsOral Glucose Tolerance Test was performed, by administering oral glucose in dose of 0.6gm/kg body weight. The capillary blood glucose levels were measured at 0, 60 and 150 min, by rat tail snipping method using (ACCUCHEK) glucometer. RESULTS: The Capillary Blood Glucose levels of Edrophonium group was less when compared to control group at all-time intervals. CONCLUSION:Edrophonium showed the hypoglycemic activity when given for five days intravenously in euglycemic albino rats through Oral Glucose Tolerance Test.
Authors: D Gautam; S-J Han; A Duttaroy; D Mears; F F Hamdan; J H Li; Y Cui; J Jeon; J Wess Journal: Diabetes Obes Metab Date: 2007-11 Impact factor: 6.577
Authors: Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Quan Zhang; Jovita Karanauskaite; Chris Partridge; Paul R Johnson; Patrik Rorsman Journal: Diabetes Date: 2008-04-04 Impact factor: 9.461
Authors: Juris J Meier; Bjoern A Menge; Thomas G K Breuer; Christophe A Müller; Andrea Tannapfel; Waldemar Uhl; Wolfgang E Schmidt; Henning Schrader Journal: Diabetes Date: 2009-06-09 Impact factor: 9.461